Adipokines and lipid profile changes in nonalcoholic fatty liver diseases patients

dc.contributor.authorLapshyna, Kateryna
dc.contributor.authorBashkirova, Anna
dc.contributor.authorZakharenkova, A.
dc.date.accessioned2017-12-06T14:28:10Z
dc.date.available2017-12-06T14:28:10Z
dc.date.issued2017
dc.description.abstractAbnormal secretion of adipokines may play a key role in the development of metabolic syndrome, including non-alcoholic fatty liver disease (NAFLD) and progression of nonalcoholic steatohepatitis (NASH). Excessive visceral adipose tissue was identified as one of the main causes leading to the development of NAFLD.ru_RU
dc.identifier.citationZakharenkova A. V. Adipokines and lipid profile changes in nonalcoholic fatty liver diseases patients / A. V. Zakharenkova, K. A. Lapshyna, A. D. Bashkirova // Science and Life : Proceedings of articles the international scientific conference, Czech Republic, Karlovy Vary - Ukraine, Kyiv, 16–17 November 2017 [Electronic resource] / Editors: I. P. Klimov, I. V. Ignatko, V. B. Mantusov. – Karlovy Vary : Skleněný Můstek, 2017. – № 79. – P. 57–59.ru_RU
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/18559
dc.language.isoenru_RU
dc.subjectadipokinesru_RU
dc.subjectNAFLDru_RU
dc.subjectlipid profileru_RU
dc.titleAdipokines and lipid profile changes in nonalcoholic fatty liver diseases patientsru_RU
dc.typeThesisru_RU

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Adipokines and lipid profile changes in nonalcoholic fatty liver diseases patients.docx
Size:
14.89 KB
Format:
Microsoft Word XML

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
11.51 KB
Format:
Item-specific license agreed upon to submission
Description: